MUC16 and nasopharyngeal carcinoma: Here, we also observed the repressed glycolysis of NPC cells in response to LV-MUC16-KD treatment, as manifested by reduced ECAR, glucose uptake, lactate production, and expression of glycolysis-related proteins.